We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The U.S. Supreme Court delivered Janssen a stinging rebuke on Monday, declining to hear its appeal of a $124 million penalty ordered by the Supreme Court of South Carolina over claims of deceptive advertising. Read More
A California supplement maker is in hot water after being accused of making drug-like claims about its products and relying on improper production methods. Read More
Drugmarkers are reporting a 20 percent improvement in securing their supply chains compared with a year ago, according to findings from a new report. Read More
Two House members are asking two embattled drugmakers for information and documents related to some of their products ahead of a Jan. 26 hearing on prescription drug pricing. Read More
Botox maker Allergan shelled out $90 million upfront to acquire dermatology drugmaker Anterios in a deal that will provide access to a pipeline of neurotoxin therapies. Read More